GlassScriptPhysician profile
Janette Lyn Wade
NPI 1760241517
$397.13
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $213.87 | 2024 | Zepbound, Mounjaro, Jardiance |
| Recordati_rare_diseases_inc. | $35.43 | 2024 | Isturisa, Signifor Lar |
| Novartis Pharmaceuticals Corporation | $30.32 | 2024 | |
| Novo Nordisk INC | $25.00 | 2024 | Rybelsus, Ozempic |
| Amgen INC. | $23.41 | 2024 | Repatha |
| Tandem Diabetes Care, INC. | $18.94 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $18.64 | 2024 | Omnipod |
| Medtronic, INC. | $16.73 | 2024 | Intellis Adaptivestim |
| Cequr Corporation | $14.79 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janette Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.